Chrysanthi-Eleni Loizou

Ms. Chrysanthi-Eleni Loizou

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2025 in Children
Verified
Journal Article
Open access
PDF file
Panagiota DiamantopoulouPanagiota Diamantopoulou
Panagiota Diamantopoulou
SKSofia Karagiannidou
Sofia Karagiannidou
Chrysanthi-Eleni LoizouChrysanthi-Eleni Loizou
Chrysanthi-Eleni Loizou
VPVassiliki Papaevangelou
Vassiliki Papaevangelou
GSGaryfallia Syridou
Garyfallia Syridou
Background: Differentiating between bacterial and viral infections in pediatric emergency care is challenging, often leading to unnecessary antibiotic use. The MeMed BV (MMBV) test is a host-response assay designed to differentiate bacterial from viral infections, but real-world data in pediatric settings remain limited. Methods: We conducted a pragmatic, single-center, prospective cohort study to assess the clinical utility of MMBV in children with acute respiratory infections or fever without source. Patients were assigned to standard of care (SOC) or MMBV testing (SOC+MMBV) based on time of presentation to the emergency department. The primary outcome was antibiotic prescribing. Secondary outcomes included diagnostic test utilization, hospitalization rates, and length of stay. Analyses were stratified by hospitalization status, clinical severity [National Institute for Health and Care Excellence (NICE) traffic light system], and patient age. Results: From July 2023 to April 2024, 343 patients were enrolled (171 SOC, 172 SOC+MMBV). In the SOC+MMBV arm, reduced antibiotic prescribing was observed among outpatients and those with non-severe signs and symptoms. Antibiotic prescribing was significantly reduced in children under five years with a low-risk profile, according to the NICE traffic light system (26.3% vs. 7.5%; p = 0.034). Multiplex PCR testing was significantly reduced in the SOC+MMBV group (28.7% vs. 16.3%; p = 0.006) compared to SOC for both inpatients and outpatients. No significant differences were observed in overall diagnostic test use or length of stay. Conclusions: MMBV improved antibiotic and diagnostic stewardship in a real-world pediatric ED setting, significantly reducing unnecessary antibiotic use among low-risk children under five and minimizing unnecessary multiplex PCR testing across the cohort.

1 April 2020 in AORTA
Verified
Journal Article
Open access
PDF file
SKStavros K Kakkos
Stavros K Kakkos
CPChrysanthi P. Papageorgopoulou
Chrysanthi P. Papageorgopoulou
KKKonstantinos Katsanos
Konstantinos Katsanos
PZPeter Zampakis
Peter Zampakis
ASAthina Siampalioti
Athina Siampalioti
AKAnastasia Kouri
Anastasia Kouri
A 71-year-old man with end-stage renal disease on hemodialysis presented with bilateral common iliac artery aneurysms diagnosed during the workup of his chronic kidney disease. On computed tomography angiography, common iliac artery aneurysm diameters measured 6.1 cm on the right side and 3.1 cm on the left side. The infrarenal aorta also had a small 3.2-cm aneurysm, but the length from the lowest left renal to the aortic bifurcation was only 6.7 cm, precluding use of most bifurcated endografts. Following an uneventful staged preoperative internal iliac artery embolization, a two-piece D-shaped Altura endograft for the aorta, with bilateral iliac components, landing at the level of the external iliac arteries was successfully performed. Postoperative course was uneventful with no endoleak or endograft migration on computerized tomographic angiography 45 days later, although billowing mimicking an endoleak was evident and will be closely followed.

11 August 2025 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
VKVasileios Kretsis
Vasileios Kretsis
Chrysanthi-Eleni LoizouChrysanthi-Eleni Loizou
Chrysanthi-Eleni Loizou
KKKonstantinos Kretsis
Konstantinos Kretsis

14 February 2026 in Viruses
Verified
Journal Article
Open access
PDF file
Chrysanthi-Eleni LoizouChrysanthi-Eleni Loizou
Chrysanthi-Eleni Loizou
Antonios GkantarasAntonios Gkantaras
Antonios Gkantaras
SKSofia Karagiannidou
Sofia Karagiannidou
GSGaryfallia Syridou
Garyfallia Syridou
DGDESPOINA GKENTZI
DESPOINA GKENTZI
EFEvangelia Farmaki
Evangelia Farmaki
Congenital Cytomegalovirus (cCMV) infection is associated with numerous long-term sequelae. This scoping review consolidates existing evidence on fetal and neonatal immune response to cCMV and their potential relevance to clinical outcomes. A systematic search was conducted in the PubMed database. Observational studies were eligible when full text was available in English and data for immune response (innate, humoral, cellular) and/or immune-related biomarkers (cytokines and molecular markers) were provided. Thirty-four studies were included. CMV-infected fetuses mount robust γδ and CD8+ T-cell responses from the second trimester of pregnancy, with the transcriptomic and cytokine profile of their amniotic fluid revealing upregulation of IFN-γ-inducible genes and cytokines. cCMV-infected neonates mount oligoclonal γδ T-cell responses and functional NK and CD8+ T-cell responses, although data on the latter’s association with symptoms at birth are contradictory. Conversely, CD4+ T-cell responses are impaired, irrespective of symptoms. T cell exhaustion is an emerging finding with unclear implications on long-term outcome. Despite shared transcriptomic profiles between symptomatic and asymptomatic neonates, a 16-gene classifier biosignature has been identified for late-onset sensorineural hearing loss. In conclusion, immune response to cCMV is characterized by a Th1 signature, with T cell exhaustion being an emerging finding warranting further investigation.

20 September 2025 in Cureus
Verified
Journal Article
Open access
PDF file
Chrysanthi-Eleni LoizouChrysanthi-Eleni Loizou
Chrysanthi-Eleni Loizou
SKSofia Karagiannidou
Sofia Karagiannidou
GSGaryfallia Syridou
Garyfallia Syridou
VPVassiliki Papaevangelou
Vassiliki Papaevangelou
Background and aim Congenital cytomegalovirus (cCMV) is the most prevalent congenital infection worldwide, associated with numerous long-term sequelae, even in infants asymptomatic at birth. However, data are lacking for asymptomatic-at-birth children, who account for the majority of cases. Thus, the aim of the study was to evaluate the olfactory function of asymptomatic cCMV-infected children and compare it to matched healthy controls using a validated odor Identification test. Methods A case-control study was conducted. Asymptomatic cCMV-infected children and healthy controls without cCMV history over the age of five were included. Cases and controls were matched at a 1:2 ratio for age and sex. Exclusion criteria included other conditions associated with transient or permanent olfactory dysfunction. A U-Sniff odor identification test (Kids Ident Test "U-Sniff"; Burghart Messtechnik GmbH, Holm, Pinneberg, Germany) was used to evaluate olfaction. Statistical analysis was conducted using IBM SPSS Statistics for Windows, version 25.0 (IBM Corp., Armonk, New York, United States). Results Overall, 63 children were included (61.9% females; median age: 7 years). No differences in olfactory function (p=0.657) or olfactory score percentile (p=0.853) were detected between cases and controls. No differences in olfactory function or olfactory score percentile were detected in two sub-analyses, where participants were stratified according to age group (5-8 years old; p=0.545 and p=0.472, respectively, and 9-11 years old; p=1.000 and p=0.088, respectively) and COVID-19 infection history (positive history; p=0.645 and p=0.694, respectively, and negative history (p=not computable and p=0.509, respectively). Conclusions Olfactory function of children with cCMV infection who were asymptomatic at birth does not seem to differ from healthy sex-and-age-matched controls.